Explore tweets tagged as #CenExel
CenExel Supports Metsera, Inc. in Successful Phase II Trial of MET-097 for Obesity and Metabolic Diseases
0
1
1
$INBS has partnered with CenExel for FDA 510(k) clinical study on non-invasive drug screening tech 🩺💊 Exciting advancement in med tech! $INBS #Healthcare #ClinicalStudy 🚀
0
0
0
BayPine has agreed to acquire CenExel Clinical Research for about $1.5 billion.
0
1
11
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway $INBS
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway $INBS
0
0
0
$INBS Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway https://t.co/fUjgLJokhr
0
0
0
BayPine Reaches Deal to Buy Clinical Trials Firm CenExel https://t.co/rUGhEuhN4U
0
0
0
CenExel Hosts Comprehensive Good Clinical Practice (GCP) Training to Strengthen Clinical Excellence Across Network
0
0
0
NEWS UPDATE: $INBS partners with @CenExel to conduct a method comparison clinical study for the final phase of its FDA 510(k) clinical study plan. The company has made substantial progress and remains on track for its planned submission to the FDA in Q4 https://t.co/r5MghLkey7
0
2
3
It’s always a pleasure to be at ISCTM and the 2023 conference in Washington DC is no different, especially when you see peers and previous colleagues from CenExel like Robert E. Litman, M.D. among many other familiar faces like AMIR KALALI, MD here to lea… https://t.co/k4qLnrsowT
0
0
0
This is how we're lining up against the Stingrays at 6:05 pm🏒 #IgniteTheFury🔥 Presented By: CenExel
0
6
10
NASDAQ Recap: $INBS Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway https://t.co/uv0REM3B7G
#NASDAQRecap #Invest #Investment #ClinicalStudy #FDA
0
1
1
The 2023 ISCTM Scientific Meeting has been full of fantastic energy, with so many amazing poster presentations (like the one my friend Elan Cohen from CenExel HRI presented), and it has been great to catch up with some fantastic colleagues both in and out… https://t.co/wYunTro88S
0
0
0